News of the layoffs come just one day after the company reported a 5% year over year revenue increase — boosting revenue to ...
AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...
After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...
It was the best of biotech times, it was the worst of biotech times: One company soars, another stumbles and a third outlines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback